Williams KD, Jurkovitz CT, Papas MA, Muther AK, Anderson SL, Anderson TL JMIR Form Res 2022 Aug;6(8):e39772 PMID: 35973033 Abstract BACKGROUND: The emergence of COVID-19 exacerbated the existing epidemic of opioid use disorder (OUD) across the United States due to the disruption of in-person treatment and support services. Increased use of technology including telehealth and